Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Diagnosing advanced lung cancer stage is a key step. It helps doctors know what to expect and the best treatment options, particularly when identifying the worst stage for lung cancer. Knowing the stages is important for making good care choices. The stage of lung cancer shows how far the disease has spread. This helps doctors choose the right treatments. The most advanced stage, often with metastatic spread, means a tougher fight ahead.

Key Takeaways

  • Understanding lung cancer stages is key for knowing what to expect.
  • The advanced stage means a harder fight.
  • Metastatic spread makes treatment harder.
  • Knowing the stage helps doctors pick the best treatments.
  • Patients and families need to know about the disease’s progress.

Understanding Lung Cancer Staging

worst stage for lung cancer
What's the Worst Stage for Lung Cancer? Understanding Stage 4 2

Lung cancer staging is key to knowing how far cancer has spread. It helps doctors choose the best treatment and predict how well a patient will do.

The TNM Classification System

The TNM system is used to stage lung cancer. It looks at three main things: the tumor’s size and where it is (T), if lymph nodes are involved (N), and if cancer has spread (M). This system helps doctors understand how far cancer has spread.

How Doctors Determine Lung Cancer Stage

Doctors figure out the lung cancer stage by checking the tumor’s size and location, if lymph nodes are affected, and if cancer has spread. They use tests like imaging studies and biopsies to get this information.

Differences Between Non-Small Cell and Small Cell Staging

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are staged differently. NSCLC uses the TNM system, while SCLC is divided into limited-stage or extensive-stage. Knowing these differences is important for creating a good treatment plan.

Overview of Lung Cancer Stages

Lung cancer staging is key in oncology. It affects treatment choices and how well a patient will do. Lung cancer stages range from I to IV, with stage I being the earliest and stage IV the most advanced.

Stage 1 Lung Cancer

Stage 1 lung cancer has a small tumor in the lungs. It hasn’t spread to lymph nodes or distant organs. This makes it easier to treat. Treatments include surgery and sometimes radiation therapy.

Stage 2 Lung Cancer

In stage 2 lung cancer, the tumor is bigger, or it has spread to nearby lymph nodes. It’s not yet widespread. Treatment options include surgery, chemotherapy, and radiation therapy.

Stage 3 Lung Cancer

Stage 3 lung cancer is split into subcategories. It means the cancer has spread to lymph nodes on the same side of the chest or nearby structures. Treatment usually involves chemotherapy, radiation therapy, and sometimes surgery.

Stage 4 Lung Cancer

Stage 4 lung cancer is the most advanced. The cancer has spread to distant organs like the brain, bones, or liver. Treatment aims to control symptoms and slow the disease’s growth. It often includes chemotherapy and targeted therapy.

Knowing these stages is vital for both patients and healthcare providers. It helps make better treatment and care decisions.

Metastatic Lung Cancer: The Most Advanced Stage

Metastatic lung cancer is the most advanced stage of lung cancer. It happens when cancer cells spread from the lungs to other parts of the body. This stage is also called Stage IV lung cancer. At this stage, the cancer is very hard to treat.

Definition and Characteristics

Metastatic lung cancer occurs when lung cancer cells break away and travel through the bloodstream or lymphatic system. They then form new tumors in other parts of the body. Common places for these new tumors include the brain, bones, liver, and adrenal glands.

The symptoms of metastatic lung cancer can vary. For example, if the cancer spreads to the brain, it can cause neurological symptoms. If it spreads to bones, it can cause pain and increase the risk of fractures.

Key characteristics include:

  • Spread to distant organs or tissues
  • Varied symptoms based on metastasis location
  • Generally considered incurable, with treatment focusing on palliation

Why Stage IV Is Considered the Worst

Stage IV lung cancer is the most advanced and severe stage. The cancer has spread beyond the lungs, making it hard to treat. The prognosis for patients with metastatic lung cancer is generally poor compared to earlier stages.

Several factors contribute to the poor prognosis. These include:

  1. The cancer’s spread to vital organs
  2. Limited treatment options for advanced disease
  3. Higher likelihood of treatment resistance

Extensive-Stage Small Cell Lung Cancer

Extensive-stage small cell lung cancer (ES-SCLC) is a subtype of small cell lung cancer. It has spread widely and is considered equivalent to Stage IV non-small cell lung cancer in terms of its advanced nature.

ES-SCLC is aggressive and often presents with widespread metastasis at diagnosis. Treatment usually involves systemic chemotherapy and sometimes radiation therapy. The goal is to control symptoms and improve quality of life.

Understanding the specifics of metastatic lung cancer, including its definition, characteristics, and the challenges it poses, is key for patients and healthcare providers alike.

Common Sites of Lung Cancer Metastasis

Lung cancer can spread to different organs, making it more complex. Knowing where it usually goes helps in managing the disease.

Lung Cancer Spread to Brain

The brain is a common place for lung cancer to spread, mainly for non-small cell lung cancer (NSCLC). Symptoms include headaches, seizures, and changes in thinking. Treatment options may include radiation therapy, surgery, or targeted therapy.

Lung Cancer Spread to Liver

Lung cancer can also spread to the liver. This can cause jaundice, abdominal pain, and tiredness. Liver function tests are key in diagnosing liver metastasis.

Bone Metastasis in Lung Cancer

Bone metastasis is common in advanced lung cancer. It can cause pain, fractures, and high calcium levels. Palliative treatments like radiation and bisphosphonates can help manage symptoms.

Adrenal Gland Metastasis

The adrenal glands are also sites for lung cancer metastasis. Though often without symptoms, they can be found through CT scans.

Other Common Metastatic Sites

Lung cancer can also spread to other areas. This includes the lungs, lymph nodes, and distant organs. The specific sites affect the prognosis and treatment plan.

Symptoms of Advanced Lung Cancer

Advanced lung cancer brings many symptoms that need careful handling. These symptoms can really affect a person’s life quality. They require a detailed care plan.

General Symptoms

Advanced lung cancer shows up with general symptoms. These symptoms are not just in the lungs but can affect the whole body. They include:

  • Weight Loss: Losing weight without trying is common. It’s often linked to eating less.
  • Fatigue: Feeling very tired that doesn’t get better with rest is common.
  • Loss of Appetite: Eating less can make weight loss and weakness worse.

Site-Specific Symptoms

Where the cancer spreads can cause different symptoms. For example:

  • Brain Metastasis: Symptoms include headaches, seizures, and changes in thinking.
  • Liver Metastasis: Symptoms include yellow skin, belly pain, and liver test changes.
  • Bone Metastasis: Bone pain and a higher risk of breaking bones are common.

Knowing these symptoms is key to managing the disease well.

When to Seek Medical Attention

It’s important for patients and their caregivers to know when symptoms get worse or new ones appear. Getting medical help is vital if there are big changes in the patient’s condition. This includes more pain, trouble breathing, or neurological symptoms.

SymptomDescriptionAction
Severe PainPain that is not controlled with current medicationContact healthcare provider for adjustment of pain management plan
Difficulty BreathingShortness of breath or feeling of insufficient airSeek immediate medical attention
Neurological SymptomsHeadaches, seizures, confusionSeek immediate medical evaluation

Diagnosing Metastatic Lung Cancer

To diagnose metastatic lung cancer, doctors use many tests. Finding out how far the cancer has spread is key. This helps decide the best treatment plan.

Imaging Tests

Imaging tests are very important. They include CT scans, PET scans, and MRI. These scans show where the main tumor is and if it has spread.

Biopsy Procedures

A biopsy is needed to confirm lung cancer. There are needle biopsy and bronchoscopy methods. The choice depends on where the tumor is.

Biomarker Testing

Biomarker testing looks for specific genetic changes in lung cancer. This helps doctors choose the right treatment and understand the patient’s outlook.

Staging Workup Process

The staging process involves several tests. These tests check the tumor size, if lymph nodes are involved, and if cancer has spread. This information helps accurately stage the cancer.


Diagnostic Test

Purpose
CT ScanIdentifies tumor size and location
PET ScanDetects metabolic activity in tumors
BiopsyConfirms cancer diagnosis
Biomarker TestingIdentifies genetic mutations

Treatment Approaches for Stage4 Lung Cancer

Stage 4 lung cancer treatment has improved, giving patients new hope. Even though the disease is advanced, there are ways to manage symptoms and slow its growth. This can also improve life quality.

Systemic Therapies

Systemic therapies treat cancer cells all over the body. For stage 4 lung cancer, these treatments are key in managing the disease.

Chemotherapy

Chemotherapy uses drugs to kill cancer cells. It’s often used with other treatments.

Immunotherapy

Immunotherapy boosts the body’s immune system to fight cancer. It’s a hopeful treatment for some stage 4 lung cancer patients.

Targeted Therapy

Targeted therapy uses drugs that target cancer cells’ specific traits. This approach is effective for patients with certain genetic mutations.

Radiation Therapy

Radiation therapy kills cancer cells or slows their growth. It’s used to relieve symptoms like pain or breathing trouble.

Palliative Treatments

Palliative treatments aim to ease symptoms and improve life quality. They include pain management, nutritional support, and more.

Treatment Selection Based on Cancer Type

The right treatment depends on the lung cancer type. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) need different approaches. Knowing the cancer type is vital for the best treatment plan.

Survival Rates and Prognosis

Lung cancer’s prognosis depends on the stage and type of cancer. Knowing survival rates helps patients and families make treatment choices.

Understanding 5-Year Survival Statistics

Five-year survival rates are key for lung cancer prognosis. They show the percentage of patients alive five years post-diagnosis. The overall 5-year survival rate for lung cancer is about 22%.

Table: 5-Year Survival Rates by Stage

Stage5-Year Survival Rate
Stage I60-80%
Stage II30-50%
Stage III10-30%
Stage IVless than 10%

Factors Affecting Prognosis

Several factors impact lung cancer prognosis. These include the cancer stage, overall health, and cancer type. Non-small cell lung cancer (NSCLC) usually has a better outlook than small cell lung cancer (SCLC) at early stages.

Recent Improvements in Outcomes

Recent years have seen better lung cancer treatment results. Advances in targeted therapies, immunotherapies, and personalized medicine have helped. These improvements have led to better survival rates, mainly for NSCLC patients.

Comparing Non-Small Cell and Small Cell Prognosis

NSCLC and SCLC have different prognoses. NSCLC grows and spreads more slowly than SCLC. This makes NSCLC patients’ prognosis better, mainly when caught early.

Knowing these differences is vital for creating effective treatment plans. It helps improve patient outcomes.

Living with Advanced Lung Cancer

Advanced lung cancer brings many challenges. It affects the body, mind, and spirit. To cope, a patient needs a plan that covers all these areas.

Managing Symptoms and Side Effects

Managing symptoms is key to a better life with advanced lung cancer. This means:

  • Using medicines to ease pain and other symptoms
  • Getting palliative care for physical and emotional relief
  • Changing lifestyle to deal with the disease’s growth

Maintaining Quality of Life

Keeping a good quality of life is important. It involves:

  • Staying close to loved ones
  • Doing things that bring happiness
  • Getting help from doctors and support groups

Emotional and Psychological Impact

Advanced lung cancer can deeply affect emotions and mind. Patients might feel anxious, depressed, and worried about the future. To help, consider:

  • Talking to a counselor or therapist
  • Joining support groups
  • Trying mindfulness and relaxation methods

These steps can lessen the emotional weight.

Support Resources and Services

There are many resources to help with advanced lung cancer. These include:

ResourceDescription
Palliative Care TeamsOffer full support for symptom management and better quality of life
Support GroupsProvide a place to share and get emotional support
Counseling ServicesGive psychological help and coping strategies

Using these resources and a caring approach can help patients with advanced lung cancer. It can make their lives better and more fulfilling.

Prevention and Early Detection

The key to managing lung cancer is through prevention and early detection strategies. Understanding risk factors and getting screened can greatly lower the risk of advanced lung cancer.

Risk Factors for Lung Cancer

Risk factors for lung cancer include smoking, secondhand smoke, radon gas, asbestos, and genetic mutations. Knowing these risks helps people take steps to prevent lung cancer.

Screening Recommendations

Adults aged 50 to 80 with a 20 pack-year smoking history should get screened annually. This applies to those who smoke or have quit in the last 15 years.

Importance of Early Diagnosis

Early detection of lung cancer greatly improves treatment outcomes. At an early stage, lung cancer is more treatable, leading to better survival rates.

Conclusion

Lung cancer is a complex and aggressive disease. Stage 4 is the lowest survival stage because it spreads widely. It’s important for patients and their families to understand this.

The aggressive stage of lung cancer means the cancer has spread far. This makes treatment hard. But, treatments like systemic therapies and palliative care can help manage symptoms and improve life quality.

Knowing about lung cancer staging and treatment options helps patients. It lets them make informed decisions and find the best care.

FAQ

What is the worst stage for lung cancer?

Stage IV is the worst stage for lung cancer. It means the cancer has spread to distant parts of the body. This includes the brain, liver, bones, or adrenal glands.

What is metastatic lung cancer?

Metastatic lung cancer is when lung cancer spreads to other parts of the body. This includes the brain, liver, bones, or adrenal glands. It’s also known as stage IV lung cancer.

What are the common sites of lung cancer metastasis?

Lung cancer often spreads to the brain, liver, bones, and adrenal glands. It can also spread to lymph nodes, lungs, and other organs.

What are the symptoms of advanced lung cancer?

Advanced lung cancer can cause symptoms like weight loss, fatigue, and pain. It can also cause headaches, seizures, or bone pain. This depends on where the cancer has spread.

How is metastatic lung cancer diagnosed?

Doctors use imaging tests like CT scans, MRI scans, and PET scans to diagnose metastatic lung cancer. They also use biopsy procedures and biomarker testing.

What are the treatment options for stage IV lung cancer?

Stage IV lung cancer can be treated with systemic therapies like chemotherapy and targeted therapy. Radiation therapy and palliative treatments are also used. These help manage symptoms and improve quality of life.

What is the prognosis for lung cancer patients?

Lung cancer prognosis depends on the disease stage and overall health. The 5-year survival rate is generally low, even for those with advanced disease.

Can lung cancer be prevented?

Lung cancer can’t be completely prevented. But, quitting smoking and avoiding carcinogens can reduce risk. Getting screened for lung cancer if at high risk is also important.

What is the importance of early detection in lung cancer?

Early detection is key in lung cancer. It can improve treatment outcomes and survival rates. Annual low-dose CT scans are recommended for those at high risk.

How does extensive-stage small cell lung cancer differ from non-small cell lung cancer?

Extensive-stage small cell lung cancer is aggressive and fast-growing. It’s treated with chemotherapy and radiation therapy. Non-small cell lung cancer is more common and can be treated with surgery, chemotherapy, and targeted therapy.

What are the survival rates for advanced non-small cell lung cancer?

Survival rates for advanced non-small cell lung cancer vary. The 5-year survival rate is around 5-10% for stage IV disease.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75